Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/02/2026 ,inter alia, to consider and approve the unaudited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Ltd has informed BSE that its Board of Directors will meet on Thursday, February 26, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended December 31, 2025 (Q3 FY26), along with the Limited Review Report by the Statutory Auditors. The trading window for dealing in the company's securities is already closed from January 1, 2026, and will remain closed until 48 hours after the financial results are made public. Any other business items may also be taken up with the Chair's permission. The scrip code is 526445.
No direct impact on the stock from this filing; it is a standard pre-results intimation. Shareholders should watch for the actual Q3 numbers when released on/after February 26, 2026, as the trading window closure restricts insider trading during this period.